Brief: Anthera Pharmaceuticals reports Q2 earnings per share $0.03

Anthera Pharmaceuticals

09/08/2017 13:30

Aug 9 (Reuters) - Anthera Pharmaceuticals Inc  ANTH.O  
    * Anthera Pharmaceuticals provides business update and 
reports 2017 second quarter financial results 
    * Q2 earnings per share $0.03 
    * Anthera Pharmaceuticals Inc - bright, phase 2 study of 
blisibimod in iga nephropathy remains on track to report topline 
data in Q3 
    * Anthera Pharmaceuticals Inc - ended Q2 of 2017 with cash 
and cash equivalents totaling $11.2 million, compared to $20.8 
million as of December 31, 2016 
 
Source text for Eikon:  ID:nGNXOCYGPa  
Further company coverage:  ANTH.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))